Relief Therapeutics Holding AG (RLFTF)

[MD2Trader]

RLFTF Competition. Unfortunately for them, way behind the 8-ball. Haven't initiated human clinical trials yet. However, like Aviptadil, this drug may have ramifications regarding future virus therapies including the common cold.

Article link: https://www.globenewswire.com/news-release/2020/12/21/2148705/0/en/Novan-Engages-Catalent-to-Develop-Intranasal-Formulation-of-Berdazimer-Sodium-for-COVID-19-Program.html

For those with ADHD: Novan initiated in vitro assessments of its NITRICIL™ platform against the novel SARS-CoV-2 coronavirus, targeting the reduction of viral burden in differentiated normal human bronchial epithelial cells. The studies were conducted at the Institute for Antiviral Research at Utah State University, and these results demonstrated the first instance of an antiviral effect from a nitric oxide-based medicine in a 3-D tissue model that has similar structure to the human airway epithelium. The results from the in vitro assessment of concentrations as low as 0.75 mg/mL demonstrated that berdazimer sodium reduced 90% of virus after repeat dosing, once daily.